Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Acq. announced
Quarterly results
CC transcript

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 4 Barbo William D (Corporate Executive VP & CCO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns: Sold 5,763 shares @ $217.24, valued at $1.3M
Exercised 5,511 options to buy @ $144.67, valued at $797.3k
08/14/2023 4 Knell Michael Gunnar (CSVP&Chief Accounting Officer) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns: Sold 1,471 shares @ $216.54, valued at $318.5k
Exercised 1,471 options to buy @ $144.67, valued at $212.8k
08/14/2023 4 FOSTER JAMES C (Chairman, President and CEO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns: Gifted 2,500 shares @ $0
08/14/2023 4 LaPlume Joseph W (EVP, Corp Strategy & Develop) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns: Sold 700 shares @ $216.52, valued at $151.6k
08/10/2023 144 Form 144 - Report of proposed sale of securities:
08/10/2023 144 Form 144 - Report of proposed sale of securities:
08/10/2023 144 Form 144 - Report of proposed sale of securities:
08/09/2023 10-Q Quarterly Report for the period ended July 1, 2023
08/09/2023 8-K Quarterly results
07/07/2023 SC 13G/A BlackRock Inc. reports a 10.2% stake in CHARLES RIVER LABORATORIES INTERNATIONAL INC
07/05/2023 4 MACKAY MARTIN (Director) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns: Granted 95 shares @ $0
06/02/2023 4 MACKAY MARTIN (Director) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns: Granted 338 shares @ $0
05/31/2023 4 LaPlume Joseph W (EVP, Corp Strategy & Develop) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns: Granted 2,189 shares @ $0
Paid exercise price by delivering 184 shares @ $194.12, valued at $35.7k
Paid exercise price by delivering 125 shares @ $194.12, valued at $24.3k
Paid exercise price by delivering 223 shares @ $194.12, valued at $43.3k
Granted 5,252 options to buy @ $194.12, valued at $1M
05/31/2023 4 Knell Michael Gunnar (CSVP&Chief Accounting Officer) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns: Granted 670 shares @ $0
Paid exercise price by delivering 36 shares @ $194.12, valued at $7k
Paid exercise price by delivering 24 shares @ $194.12, valued at $4.7k
Paid exercise price by delivering 36 shares @ $194.12, valued at $7k
Granted 1,607 options to buy @ $194.12, valued at $312k
05/31/2023 4 Pease Flavia (Corporate Executive VP & CFO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns: Granted 2,215 shares @ $0
Paid exercise price by delivering 137 shares @ $194.12, valued at $26.6k
Granted 5,314 options to buy @ $194.12, valued at $1M
05/31/2023 4 FOSTER JAMES C (Chairman, President and CEO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns: Paid exercise price by delivering 1,274 shares @ $194.12, valued at $247.3k
Granted 28,176 options to buy @ $194.12, valued at $5.5M
05/31/2023 4 Barbo William D (Corporate Executive VP & CCO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns: Granted 1,958 shares @ $0
Paid exercise price by delivering 166 shares @ $194.12, valued at $32.2k
Paid exercise price by delivering 112 shares @ $194.12, valued at $21.7k
Paid exercise price by delivering 202 shares @ $194.12, valued at $39.2k
Granted 4,696 options to buy @ $194.12, valued at $911.6k
05/31/2023 4 Girshick Birgit (Corporate Executive VP & COO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns: Granted 3,812 shares @ $0
Paid exercise price by delivering 242 shares @ $194.12, valued at $47k
Paid exercise price by delivering 132 shares @ $194.12, valued at $25.6k
Paid exercise price by delivering 216 shares @ $194.12, valued at $41.9k
Granted 9,145 options to buy @ $194.12, valued at $1.8M
05/31/2023 4 Parisotto Shannon M (CEVP, Disc & Safety Assessment) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns: Granted 1,700 shares @ $0
Paid exercise price by delivering 105 shares @ $194.12, valued at $20.4k
Paid exercise price by delivering 71 shares @ $194.12, valued at $13.8k
Paid exercise price by delivering 110 shares @ $194.12, valued at $21.4k
Granted 4,078 options to buy @ $194.12, valued at $791.6k
05/31/2023 4 Creamer Victoria L (EVP & Chief People Officer) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns: Granted 2,009 shares @ $0
Paid exercise price by delivering 170 shares @ $194.12, valued at $33k
Paid exercise price by delivering 115 shares @ $194.12, valued at $22.3k
Paid exercise price by delivering 190 shares @ $194.12, valued at $36.9k
Granted 4,820 options to buy @ $194.12, valued at $935.7k
05/25/2023 SD Form SD - Specialized disclosure report:
05/17/2023 4 WALLMAN RICHARD F (Director) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns: Granted 664 shares @ $0
Granted 1,669 options to buy @ $192.36, valued at $321k
05/17/2023 4 FOSTER JAMES C (Chairman, President and CEO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns: Gifted 3,811 shares @ $0
Gifted 3,812 shares @ $0
05/17/2023 4 Llado George Sr. (Director) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns: Granted 664 shares @ $0
Granted 1,669 options to buy @ $192.36, valued at $321k
05/17/2023 4 Kochevar Deborah Turner (Director) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns: Granted 664 shares @ $0
Granted 1,669 options to buy @ $192.36, valued at $321k
05/17/2023 4 BERTOLINI ROBERT J (Director) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns: Granted 664 shares @ $0
Granted 468 shares @ $0
Granted 1,669 options to buy @ $192.36, valued at $321k
05/17/2023 4 Andrews Nancy C (Director) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns: Granted 664 shares @ $0
Granted 1,669 options to buy @ $192.36, valued at $321k
05/15/2023 4 LaPlume Joseph W (EVP, Corp Strategy & Develop) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns: Sold 950 shares @ $193.02, valued at $183.4k
Sold 9 shares @ $194.07, valued at $1.7k
05/15/2023 4 MASSARO GEORGE (Director) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns: Sold 288 shares @ $193.43, valued at $55.7k
05/15/2023 144 Form 144 - Report of proposed sale of securities:
05/12/2023 144 Form 144 - Report of proposed sale of securities:
05/11/2023 144 Form 144 - Report of proposed sale of securities:
05/11/2023 10-Q Quarterly Report for the period ended April 1, 2023
05/11/2023 8-K Quarterly results
Docs: "Charles River Laboratories Announces First-Quarter 2023 Results – First-Quarter Revenue of $1.03 Billion – – First-Quarter GAAP Earnings per Share of $2.01 and Non-GAAP Earnings per Share of $2.78 – – Updates 2023 Guidance –"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy